Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay.

Mo X, Qi Q, Ivanov AA, Niu Q, Luo Y, Havel J, Goetze R, Bell S, Moreno CS, Cooper LA, Johns MA, Khuri FR, Du Y, Fu H.

Mol Pharmacol. 2017 Apr;91(4):339-347. doi: 10.1124/mol.116.107623. Epub 2017 Jan 13.

PMID:
28087810
2.

Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.

Nakagawa S, Wei L, Song WM, Higashi T, Ghoshal S, Kim RS, Bian CB, Yamada S, Sun X, Venkatesh A, Goossens N, Bain G, Lauwers GY, Koh AP, El-Abtah M, Ahmad NB, Hoshida H, Erstad DJ, Gunasekaran G, Lee Y, Yu ML, Chuang WL, Dai CY, Kobayashi M, Kumada H, Beppu T, Baba H, Mahajan M, Nair VD, Lanuti M, Villanueva A, Sangiovanni A, Iavarone M, Colombo M, Llovet JM, Subramanian A, Tager AM, Friedman SL, Baumert TF, Schwarz ME, Chung RT, Tanabe KK, Zhang B, Fuchs BC, Hoshida Y; Precision Liver Cancer Prevention Consortium.

Cancer Cell. 2016 Dec 12;30(6):879-890. doi: 10.1016/j.ccell.2016.11.004.

PMID:
27960085
3.

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.

Larsen JE, Nathan V, Osborne JK, Farrow RK, Deb D, Sullivan JP, Dospoy PD, Augustyn A, Hight SK, Sato M, Girard L, Behrens C, Wistuba II, Gazdar AF, Hayward NK, Minna JD.

J Clin Invest. 2016 Sep 1;126(9):3219-35. doi: 10.1172/JCI76725. Epub 2016 Aug 8.

4.

miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth.

Mihailovich M, Bremang M, Spadotto V, Musiani D, Vitale E, Varano G, Zambelli F, Mancuso FM, Cairns DA, Pavesi G, Casola S, Bonaldi T.

Nat Commun. 2015 Nov 10;6:8725. doi: 10.1038/ncomms9725.

5.

Neuron navigator 2 overexpression indicates poor prognosis of colorectal cancer and promotes invasion through the SSH1L/cofilin-1 pathway.

Tan F, Zhu H, Tao Y, Yu N, Pei Q, Liu H, Zhou Y, Xu H, Song X, Li Y, Zhou Z, He X, Zhang X, Pei H.

J Exp Clin Cancer Res. 2015 Oct 9;34:117. doi: 10.1186/s13046-015-0237-3.

6.

Genome-wide analysis of the oxyntic proliferative isthmus zone reveals ASPM as a possible gastric stem/progenitor cell marker over-expressed in cancer.

Vange P, Bruland T, Beisvag V, Erlandsen SE, Flatberg A, Doseth B, Sandvik AK, Bakke I.

J Pathol. 2015 Dec;237(4):447-59. doi: 10.1002/path.4591. Epub 2015 Aug 26.

7.

Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression.

Patel N, Itakura T, Jeong S, Liao CP, Roy-Burman P, Zandi E, Groshen S, Pinski J, Coetzee GA, Gross ME, Fini ME.

PLoS One. 2015 Feb 18;10(2):e0117758. doi: 10.1371/journal.pone.0117758. eCollection 2015.

8.

Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.

Kopecka J, Campia I, Jacobs A, Frei AP, Ghigo D, Wollscheid B, Riganti C.

Oncotarget. 2015 Mar 30;6(9):6776-93.

9.

A unique four-hub protein cluster associates to glioblastoma progression.

Simeone P, Trerotola M, Urbanella A, Lattanzio R, Ciavardelli D, Di Giuseppe F, Eleuterio E, Sulpizio M, Eusebi V, Pession A, Piantelli M, Alberti S.

PLoS One. 2014 Jul 22;9(7):e103030. doi: 10.1371/journal.pone.0103030. eCollection 2014.

10.
11.

MYC cofactors: molecular switches controlling diverse biological outcomes.

Hann SR.

Cold Spring Harb Perspect Med. 2014 Jun 17;4(9):a014399. doi: 10.1101/cshperspect.a014399. Review.

12.

Controlling for gene expression changes in transcription factor protein networks.

Banks CA, Lee ZT, Boanca G, Lakshminarasimhan M, Groppe BD, Wen Z, Hattem GL, Seidel CW, Florens L, Washburn MP.

Mol Cell Proteomics. 2014 Jun;13(6):1510-22. doi: 10.1074/mcp.M113.033902. Epub 2014 Apr 10.

13.

The Aryl-Hydrocarbon Receptor Protein Interaction Network (AHR-PIN) as Identified by Tandem Affinity Purification (TAP) and Mass Spectrometry.

Tappenden DM, Hwang HJ, Yang L, Thomas RS, Lapres JJ.

J Toxicol. 2013;2013:279829. doi: 10.1155/2013/279829. Epub 2013 Dec 5.

14.

Cellular MYCro economics: Balancing MYC function with MYC expression.

Levens D.

Cold Spring Harb Perspect Med. 2013 Nov 1;3(11). pii: a014233. doi: 10.1101/cshperspect.a014233. Review. Erratum in: Cold Spring Harb Perspect Med. 2013 Dec;3(12):a022483.

15.

Human disease locus discovery and mapping to molecular pathways through phylogenetic profiling.

Tabach Y, Golan T, Hernández-Hernández A, Messer AR, Fukuda T, Kouznetsova A, Liu JG, Lilienthal I, Levy C, Ruvkun G.

Mol Syst Biol. 2013 Oct 1;9:692. doi: 10.1038/msb.2013.50.

16.

Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.

Farrell AS, Pelz C, Wang X, Daniel CJ, Wang Z, Su Y, Janghorban M, Zhang X, Morgan C, Impey S, Sears RC.

Mol Cell Biol. 2013 Aug;33(15):2930-49. doi: 10.1128/MCB.01455-12. Epub 2013 May 28.

17.

Myc binds the pluripotency factor Utf1 through the basic-helix-loop-helix leucine zipper domain.

Laskowski AI, Knoepfler PS.

Biochem Biophys Res Commun. 2013 Jun 14;435(4):551-6. doi: 10.1016/j.bbrc.2013.04.100. Epub 2013 May 9.

18.

GPR158, an orphan member of G protein-coupled receptor Family C: glucocorticoid-stimulated expression and novel nuclear role.

Patel N, Itakura T, Gonzalez JM Jr, Schwartz SG, Fini ME.

PLoS One. 2013;8(2):e57843. doi: 10.1371/journal.pone.0057843. Epub 2013 Feb 25.

19.

c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D.

Cell. 2012 Sep 28;151(1):68-79. doi: 10.1016/j.cell.2012.08.033.

20.

Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding.

Andresen C, Helander S, Lemak A, Farès C, Csizmok V, Carlsson J, Penn LZ, Forman-Kay JD, Arrowsmith CH, Lundström P, Sunnerhagen M.

Nucleic Acids Res. 2012 Jul;40(13):6353-66. Epub 2012 Mar 28.

Supplemental Content

Support Center